Characteristics | All patients with initial nonshockable rhythm,n(%) | Subsequently shocked cohort,n(%) | Subsequently not-shocked cohort,n(%) | P-value | |||
---|---|---|---|---|---|---|---|
Total patients in each group (%) | 569,937 | (100) | 21,944 | (3.9) | 547,993 | (96.1) | Â |
Year | Â | Â | Â | Â | Â | Â | Â |
2005 | 87,978 | (15.4) | 3,978 | (18.1) | 84,000 | (15.3) | <0.0001 |
2006 | 90,942 | (16.0) | 3,618 | (16.5) | 87,324 | (15.9) | Â |
2007 | 88,710 | (15.6) | 3,465 | (15.8) | 85,245 | (15.6) | Â |
2008 | 97,211 | (17.1) | 3,504 | (16.0) | 93,707 | (17.1) | Â |
2009 | 99,024 | (17.3) | 3,680 | (16.8) | 95,344 | (17.4) | Â |
2010 | 106,072 | (18.6) | 3,699 | (16.9) | 102,373 | (18.7) | Â |
Age, yr | 77 | (65 to 85) | 75 | (62 to 83) | 77 | (66 to 85) | <0.0001 |
Male | 324,683 | (57.0) | 13,819 | (63.0) | 310,864 | (56.7) | <0.0001 |
Witnessed OHCA | 204,687 | (35.9) | 10,595 | (48.3) | 194,092 | (35.4) | <0.0001 |
Witnessed OHCA by EMS personnel | 30,341 | (5.3) | 1,226 | (5.6) | 29,115 | (5.3) | 0.076 |
Bystander CPR | 224,273 | (39.4) | 8,842 | (40.3) | 215,431 | (39.3) | 0.0035 |
Presumed cardiac cause | 303,947 | (53.3) | 14,357 | (65.4) | 289,590 | (52.9) | <0.0001 |
Initial cardiac rhythm | Â | Â | Â | Â | Â | Â | Â |
Pulseless electrical activity | 138,044 | (24.2) | 8,008 | (36.5) | 130,036 | (23.7) | <0.0001 |
Asystole | 431,893 | (75.8) | 13,936 | (63.5) | 417,957 | (76.3) | Â |
Call-to-response time, min | 7.0 | (5 to 9) | 7.0 | (5 to 9) | 7.0 | (5 to 9) | <0.0001 |
Time from the initiation of CPR by EMS personnel to hospital arrival, min | 30 | (24 to 37) | 32 | (26 to 39) | 30 | (24 to 36) | <0.0001 |
Shock delivery time, minb | 20.0 | (15 to 27) | 20.0 | (15 to 27) | No data | Â | |
Epinephrine administration | 33,772 | (5.9) | 2,883 | (13.1) | 30,889 | (5.6) | <0.0001 |
Epinephrine administration time, minc | 15 | (10 to 20) | 14 | (10 to 20) | 15 | (10 to 20) | 0.006 |
Outcomes | Â | Â | Â | Â | Â | Â | Â |
Prehospital ROSC | 24,028 | (4.2) | 1,676 | (7.6) | 22,352 | (4.1) | <0.0001 |
1-month survival | 15,258 | (2.7) | 1,055 | (4.8) | 14,203 | (2.6) | <0.0001 |
1-month favorable neurological outcome (CPC category 1 or 2) | 3,694 | (0.6) | 393 | (1.8) | 3,301 | (0.6) | <0.0001 |